We are live on ! Find out more
INBX

Inhibrx, Inc. Common Stock

Delisted

INBX was delisted on the 29th of May, 2024.

51 hedge funds and large institutions have $513M invested in Inhibrx, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

190% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 10

107% more capital invested

Capital invested by funds: $248M → $513M (+$266M)

59% more funds holding

Funds holding: 3251 (+19)

43% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 7

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
51
Holders Change
+19
Holders Change %
+59.38%
% of All Funds
0.9%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
29
Increased
10
Reduced
7
Closed
10
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Wells Fargo
26
Wells Fargo
California
$701K +$374K +14,049 +195%
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$537K +$433K +16,275 New
Goldman Sachs
28
Goldman Sachs
New York
$413K -$2.05M -77,213 -86%
California State Teachers Retirement System (CalSTRS)
29
California State Teachers Retirement System (CalSTRS)
California
$405K +$327K +12,292 New
M&T Bank
30
M&T Bank
New York
$382K
IC
31
Ikarian Capital
Texas
$266K +$215K +8,076 New
VEA
32
Virtus ETF Advisers
New York
$235K +$190K +7,133 New
AC
33
Athanor Capital
New York
$217K +$175K +6,573 New
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$214K +$173K +6,490 New
Morgan Stanley
35
Morgan Stanley
New York
$203K +$164K +6,167 New
Deutsche Bank
36
Deutsche Bank
Germany
$188K +$152K +5,701 New
New York State Common Retirement Fund
37
New York State Common Retirement Fund
New York
$155K +$125K +4,700 New
MIM
38
MetLife Investment Management
New Jersey
$131K +$105K +3,963 New
Bank of America
39
Bank of America
North Carolina
$92K -$130K -4,889 -64%
MLICM
40
Metropolitan Life Insurance Company (MetLife)
New York
$91.3K +$73.7K +2,769 New
SO
41
STRS Ohio
Ohio
$65K +$53.2K +2,000 New
UBS Group
42
UBS Group
Switzerland
$64K +$22.3K +839 +77%
Osaic Holdings
43
Osaic Holdings
Arizona
$63K
Citigroup
44
Citigroup
New York
$54K +$43.4K +1,632 New
Bank of Montreal
45
Bank of Montreal
Ontario, Canada
$42K +$33.9K +1,274 New
Legal & General Group
46
Legal & General Group
United Kingdom
$28K +$22.8K +858 New
TRCT
47
Tower Research Capital (TRC)
New York
$26K +$20.6K +774 New
Canada Life
48
Canada Life
Manitoba, Canada
$22K +$17.6K +662 New
AIP
49
Ameritas Investment Partners
Nebraska
$22K +$18.1K +681 New
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$19K +$5.08K +191 +50%

INBX Hedge Fund Activity: Q4 2020 in Review

51 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Inhibrx, Inc. Common Stock (INBX) for Q4 2020, worth a combined $513M — up 107% from $248M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new INBX positions and 10 closed out — a net gain of 19 holders — while 10 added to existing stakes and 7 trimmed.

The largest buyer was ArrowMark Colorado Holdings, adding an estimated $28.1M. The largest seller was Logos Global Management, exiting entirely with an estimated $5.61M sold.

  • 51 institutional investors held Inhibrx, Inc. Common Stock (INBX) as of Q4 2020, up from 32 in Q3 2020.
  • Funds reported $513M of Inhibrx, Inc. Common Stock stock for Q4 2020, up 107% quarter-over-quarter.
  • 29 funds opened new Inhibrx, Inc. Common Stock positions in Q4 2020 and 10 closed out, a net change of +19 holders.
  • The largest Inhibrx, Inc. Common Stock buyer in Q4 2020 was ArrowMark Colorado Holdings, an estimated $28.1M added.
  • The largest Inhibrx, Inc. Common Stock seller in Q4 2020 was Logos Global Management, an estimated $5.61M sold.

Based on aggregated 13F filings for Q4 2020.